Christine A. Kirvan

1.1k total citations
11 papers, 816 citations indexed

About

Christine A. Kirvan is a scholar working on Public Health, Environmental and Occupational Health, Neurology and Clinical Psychology. According to data from OpenAlex, Christine A. Kirvan has authored 11 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 4 papers in Neurology and 3 papers in Clinical Psychology. Recurrent topics in Christine A. Kirvan's work include Streptococcal Infections and Treatments (6 papers), Obsessive-Compulsive Spectrum Disorders (3 papers) and Myasthenia Gravis and Thymoma (3 papers). Christine A. Kirvan is often cited by papers focused on Streptococcal Infections and Treatments (6 papers), Obsessive-Compulsive Spectrum Disorders (3 papers) and Myasthenia Gravis and Thymoma (3 papers). Christine A. Kirvan collaborates with scholars based in United States, Norway and Canada. Christine A. Kirvan's co-authors include Madeleine W. Cunningham, Susan E. Swedo, Janet S. Heuser, Lisa A. Snider, David Kurahara, Carol J. Cox, Mark Agius, Stanley D. Kosanke, Robert H. Fairclough and Anne L. Schafer and has published in prestigious journals such as Nature Medicine, The Journal of Immunology and Annals of the New York Academy of Sciences.

In The Last Decade

Christine A. Kirvan

11 papers receiving 798 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine A. Kirvan United States 10 399 318 192 104 103 11 816
Lisa A. Snider United States 15 756 1.9× 332 1.0× 154 0.8× 62 0.6× 55 0.5× 16 1.1k
Janet S. Heuser United States 6 162 0.4× 118 0.4× 108 0.6× 147 1.4× 73 0.7× 6 625
Z H Abdin United States 10 220 0.6× 142 0.4× 189 1.0× 115 1.1× 70 0.7× 15 631
Carol J. Cox United States 11 215 0.5× 161 0.5× 83 0.4× 151 1.5× 43 0.4× 16 900
Rick Dersch Germany 21 137 0.3× 555 1.7× 75 0.4× 56 0.5× 332 3.2× 68 1.4k
Maria Joaquina Marques‐Dias Brazil 15 230 0.6× 176 0.6× 228 1.2× 10 0.1× 58 0.6× 38 1.0k
Maya Latimer Australia 10 260 0.7× 172 0.5× 44 0.2× 42 0.4× 64 0.6× 18 512
Sekhar Pillai Australia 14 98 0.2× 881 2.8× 35 0.2× 52 0.5× 177 1.7× 17 1.1k
P. K. Coyle United States 10 52 0.1× 212 0.7× 64 0.3× 51 0.5× 206 2.0× 14 1.1k
Sedat Işıkay Türkiye 11 212 0.5× 46 0.1× 109 0.6× 19 0.2× 88 0.9× 64 689

Countries citing papers authored by Christine A. Kirvan

Since Specialization
Citations

This map shows the geographic impact of Christine A. Kirvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine A. Kirvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine A. Kirvan more than expected).

Fields of papers citing papers by Christine A. Kirvan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine A. Kirvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine A. Kirvan. The network helps show where Christine A. Kirvan may publish in the future.

Co-authorship network of co-authors of Christine A. Kirvan

This figure shows the co-authorship network connecting the top 25 collaborators of Christine A. Kirvan. A scholar is included among the top collaborators of Christine A. Kirvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine A. Kirvan. Christine A. Kirvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kirvan, Christine A., Susan E. Swedo, Harry R. Hill, et al.. (2023). IgG2 rules: N-acetyl-β-D-glucosamine-specific IgG2 and Th17/Th1 cooperation may promote the pathogenesis of acute rheumatic heart disease and be a biomarker of the autoimmune sequelae of Streptococcus pyogenes. Frontiers in Cardiovascular Medicine. 9. 919700–919700. 10 indexed citations
2.
Kirvan, Christine A., et al.. (2013). Identification of Streptococcal M-Protein Cardiopathogenic Epitopes in Experimental Autoimmune Valvulitis. Journal of Cardiovascular Translational Research. 7(2). 172–181. 32 indexed citations
3.
Agius, Mark, et al.. (2009). High prevalence of anti-α-crystallin antibodies in multiple sclerosis: correlation with severity and activity of disease. Acta Neurologica Scandinavica. 100(3). 139–147. 12 indexed citations
4.
Kirvan, Christine A., Carol J. Cox, Susan E. Swedo, & Madeleine W. Cunningham. (2007). Tubulin Is a Neuronal Target of Autoantibodies in Sydenham’s Chorea. The Journal of Immunology. 178(11). 7412–7421. 105 indexed citations
5.
Kirvan, Christine A., Susan E. Swedo, Lisa A. Snider, & Madeleine W. Cunningham. (2006). Antibody-mediated neuronal cell signaling in behavior and movement disorders. Journal of Neuroimmunology. 179(1-2). 173–179. 148 indexed citations
6.
Kirvan, Christine A., Susan E. Swedo, David Kurahara, & Madeleine W. Cunningham. (2006). Streptococcal mimicry and antibody-mediated cell signaling in the pathogenesis of Sydenham's chorea. Autoimmunity. 39(1). 21–29. 120 indexed citations
7.
Kirvan, Christine A., Susan E. Swedo, Janet S. Heuser, & Madeleine W. Cunningham. (2003). Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nature Medicine. 9(7). 914–920. 332 indexed citations
8.
Richman, David P., Mark Agius, Christine A. Kirvan, et al.. (1998). Antibody Effector Mechanisms in Myasthenia Gravis: The Complement Hypothesisa. Annals of the New York Academy of Sciences. 841(1). 450–465. 17 indexed citations
9.
Kirvan, Christine A., et al.. (1998). Expression and Initial Characterization of Recombinant Antiacetylcholine Receptor Antibodies in Experimental Autoimmune Myasthenia Gravisa. Annals of the New York Academy of Sciences. 841(1). 466–468. 1 indexed citations
10.
Agius, Mark, Christine A. Kirvan, Anne L. Schafer, et al.. (1998). Rapsyn Antibodies in Myasthenia Gravisa. Annals of the New York Academy of Sciences. 841(1). 516–521. 30 indexed citations
11.
Agius, Mark, et al.. (1998). Antibodies to AChR, Synapse‐organizing Proteins, Titin, and Other Muscle Proteins in Morvan's Fibrillary Choreaa. Annals of the New York Academy of Sciences. 841(1). 522–524. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa A. Snider Breakdown of academic impact, for papers by Janet S. Heuser Breakdown of academic impact, for papers by Z H Abdin Breakdown of academic impact, for papers by Carol J. Cox Breakdown of academic impact, for papers by Rick Dersch Breakdown of academic impact, for papers by Maria Joaquina Marques‐Dias Breakdown of academic impact, for papers by Maya Latimer Breakdown of academic impact, for papers by Sekhar Pillai Breakdown of academic impact, for papers by P. K. Coyle Breakdown of academic impact, for papers by Sedat Işıkay
Rankless by CCL
2026